Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Immune-Mediated HepatitisLiver FailureHepatocellular Carcinoma
Interventions
OTHER

DPMAS+LPE

Patients will receive treatment of double plasma molecular adsorption system (DPMAS) and low volume plasma exchange (LPE) for three times in two weeks. The volume of plasma adsorption in DPMAS is 5000\~6000 millilitre. The volume of fresh frozen plasma used in LPE is 1000 millilitre.

OTHER

PE

Patients will receive treatment of plasma exchange (PE) for three times in two weeks. The volume of fresh frozen plasma used in PE is 2000 millilitre.

OTHER

Comprehensive internal medical treatment

Patients will receive comprehensive internal medical treatment.

Trial Locations (1)

510630

RECRUITING

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER